Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Emmaus Life Sciences Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
EMMA
Over the counter
2834
https://www.emmausmedical.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Emmaus Life Sciences Inc
Emmaus Life Sciences Reports Delayed Filing of Annual Report
- Apr 15th, 2024 8:07 pm
Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico
- Feb 2nd, 2024 3:00 pm
Emmaus Life Sciences Reports Q3 2023 Financial Results
- Nov 14th, 2023 2:30 pm
Emmaus Life Sciences Reports Management Changes
- Aug 23rd, 2023 1:00 pm
Emmaus Life Sciences Reports Q2 2023 Financial Results
- Aug 14th, 2023 7:54 pm
Emmaus Life Sciences Receives Marketing Authorization for EndariĀ® in Oman
- Jul 13th, 2023 7:10 pm
Emmaus Life Sciences Receives EndariĀ® Marketing Authorization from the Bahrain NHRA
- May 31st, 2023 6:11 pm
Emmaus Life Sciences Reports Q1 2023 Financial Results and Provides Business Update
- May 15th, 2023 1:30 pm
Scroll